Highlands Ranch, COLORADO2 Active Studies

Ankylosing Spondylitis Clinical Trials in Highlands Ranch, COLORADO

Find 2 actively recruiting ankylosing spondylitis clinical trials in Highlands Ranch, COLORADO. Connect with local research sites and explore new treatment options.

2
Active Trials
1
Sponsors
1,380
Enrolling

Recruiting Ankylosing Spondylitis Studies in Highlands Ranch

About Ankylosing Spondylitis Clinical Trials in Highlands Ranch

Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.

There are currently 2 ankylosing spondylitis clinical trials recruiting participants in Highlands Ranch, COLORADO. These studies are seeking a combined 1,380 participants. Research is being sponsored by Merck Sharp & Dohme LLC. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ankylosing Spondylitis Clinical Trials in Highlands Ranch — FAQ

Are there ankylosing spondylitis clinical trials in Highlands Ranch?

Yes, there are 2 ankylosing spondylitis clinical trials currently recruiting in Highlands Ranch, COLORADO. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Highlands Ranch?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Highlands Ranch research site will contact you about next steps.

Are clinical trials in Highlands Ranch free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Highlands Ranch studies also compensate for your time and travel.

What ankylosing spondylitis treatments are being tested?

The 2 active trials in Highlands Ranch are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.

Data updated March 2, 2026 from ClinicalTrials.gov